Baltimore wins $266 million in opioid case against distributors [Yahoo! Finance Canada]
Cencora, Inc. (COR)
Last cencora, inc. earnings: 4/30 06:30 am
Check Earnings Report
US:NYSE Investor Relations:
investors.coresite.com/investor-overview
Company Research
Source: Yahoo! Finance Canada
A six-person jury in the Circuit Court for Baltimore found McKesson responsible for $192 million and Cencora for $74 million on Tuesday following a nearly two-month trial. The amount represents damages compensating the city for harms the companies were found to have caused. Baltimore, which has been hit hard by the opioid crisis, opted out of large national opioid settlements in recent years in the hope of winning more money on its own. In 2022, Baltimore recorded 904 opioid overdose deaths, out of a total population of about 569,000, while the national opioid overdose death rate was about 25 per 100,000. Next month, the city is expected to ask Judge Lawrence Fletcher-Hill for about $9 billion from the companies to pay for the cost of addressing the opioid crisis going forward. That is a legal remedy known as abatement, and is distinct from civil damages. Baltimore accuses Cencora, formerly called AmerisourceBergen, and McKesson of ignoring red flags that opioids they supplied
Show less
Read more
Impact Snapshot
Event Time:
COR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
COR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
COR alerts
High impacting Cencora, Inc. news events
Weekly update
A roundup of the hottest topics
COR
News
- Cencora, Inc. (NYSE: COR) had its price target lowered by analysts at Wells Fargo & Company from $249.00 to $237.00. They now have an "equal weight" rating on the stock.MarketBeat
- Cencora Closes $1.8 Billion Senior Notes OfferingBusiness Wire
- Avalere Health welcomes Executive Vice President to fuse policy, access and marketing in a new offering [Yahoo! Finance]Yahoo! Finance
- Cencora, Inc. (NYSE: COR) is now covered by analysts at Mizuho. They set an "outperform" rating and a $280.00 price target on the stock.MarketBeat
- Cencora Prices $500 Million 4.625% Senior Notes Due 2027, $600 Million 4.850% Senior Notes Due 2029 and $700 Million 5.150% Senior Notes Due 2035Business Wire
COR
Earnings
- 11/6/24 - Beat
COR
Sec Filings
- 12/20/24 - Form 4
- 12/20/24 - Form 4
- 12/20/24 - Form 4
- COR's page on the SEC website